| P2093 | author name string | Bohuslav Dvorak | |
| | Ludmila Khailova | |
| | Junji Hoshiba | |
| | Melissa D Halpern | |
| | Masako Yajima | |
| | Charity Reynolds | |
| | Dania Molla-Hosseini | |
| | Kelly Arganbright | |
| P2860 | cites work | Neonatal necrotizing enterocolitis: a nine-year experience | Q44101094 |
| | Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis | Q44279092 |
| | Reduced thymic size and numbers of splenic CD4+ and CD8+ cells in artificially reared mouse pups | Q47266413 |
| | Overview of interleukin-18: more than an interferon-gamma inducing factor | Q47992381 |
| | Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. | Q52927303 |
| | Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis. | Q53646439 |
| | Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. | Q54798443 |
| | Neonatal necrotizing enterocolitis: a nine-year experience. II. Outcome assessment | Q70815501 |
| | Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease | Q71637010 |
| | Induction of nitric oxide synthase in rat intestine and its association with tissue injury | Q72085347 |
| | Nitric oxide synthase activity in ulcerative colitis and Crohn's disease | Q72088538 |
| | Greatly increased luminal nitric oxide in ulcerative colitis | Q72898562 |
| | The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis | Q73097568 |
| | Interleukin-18 activates NF-kappaB in murine T helper type 1 cells | Q73401336 |
| | Interleukin-18 and Crohn's disease | Q73430673 |
| | Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model | Q73820060 |
| | Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis | Q73918754 |
| | Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model | Q77371874 |
| | IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock | Q77379012 |
| | Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model | Q78176971 |
| | Method for hand-feeding mouse pups with nursing bottles | Q80155104 |
| | A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB | Q24321775 |
| | NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 |
| | Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway | Q28302102 |
| | Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis | Q28564241 |
| | Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha | Q28572801 |
| | Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination | Q28615601 |
| | IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells | Q30304035 |
| | A role for transcription factor NF-kappa B in intestinal inflammation | Q33596380 |
| | The physicochemical environment of the neonatal intestine | Q33610626 |
| | The use of human milk and breastfeeding in premature infants. | Q33679845 |
| | Necrotizing enterocolitis of the newborn: pathogenetic concepts in perspective | Q33720815 |
| | The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection | Q33860197 |
| | Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network | Q33929595 |
| | Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity | Q34408472 |
| | Regulation of cytokine signaling and inflammation | Q34830660 |
| | Neonatal necrotizing enterocolitis: an overview | Q35177882 |
| | Activation of nuclear factor kappa B inflammatory bowel disease | Q35350256 |
| | Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage | Q35594688 |
| | Bile acids induce ileal damage during experimental necrotizing enterocolitis | Q36160241 |
| | NF-kappaB inhibition enhances peroxynitrite-induced enterocyte apoptosis | Q40717021 |
| | Necrotizing enterocolitis: a review of pathogenetic mechanisms and implications for prevention | Q40919392 |
| | Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention | Q40978132 |
| | Bioactive IL-18 expression is up-regulated in Crohn's disease | Q41675600 |
| | Role of NF-kappaB in immune and inflammatory responses in the gut. | Q41878721 |
| P433 | issue | 1 | |
| P921 | main subject | necrotizing enterocolitis | Q10859678 |
| P304 | page(s) | G20-6 | |
| P577 | publication date | 2007-10-18 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Decreased development of necrotizing enterocolitis in IL-18-deficient mice | |
| P478 | volume | 294 | |